| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/21/2007 | EP1754784A2 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 02/21/2007 | EP1754783A1 Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 02/21/2007 | EP1754485A1 Remedy for neurodegenerative diseases |
| 02/21/2007 | EP1754052A1 Modulators of biochemical characteristics |
| 02/21/2007 | EP1753866A2 Plastid transit peptides |
| 02/21/2007 | EP1753865A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 02/21/2007 | EP1753860A2 Intervertebral disc repair, methods and devices therefor |
| 02/21/2007 | EP1753859A1 A method for producing red blood cells |
| 02/21/2007 | EP1753524A1 A device for controlling and regulating the physical-biochemical condition of a liquid mixture |
| 02/21/2007 | EP1753459A2 Composition and method for improving pancreatic islet cell survival |
| 02/21/2007 | EP1753451A2 Local delivery of growth factors for stem cell transplantation |
| 02/21/2007 | EP1753445A2 Treatment of ocular diseases and disorders using lantibiotic compositions |
| 02/21/2007 | EP1753439A2 Use of umbilical cord blood stem cells to treat ischemic event |
| 02/21/2007 | EP1578955A4 Candida kefyr cytosine deaminase |
| 02/21/2007 | EP1517913B1 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 02/21/2007 | EP1390474B1 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 02/21/2007 | EP1339831B1 In vitro synthesis of a layered cell sorted tissue |
| 02/21/2007 | EP1294912B1 Gtp binding stress-related protein and methods of its use in plants |
| 02/21/2007 | EP1242605B1 Artificial promoters for protein expression in plants |
| 02/21/2007 | EP1212438B8 Flax seed specific promoters |
| 02/21/2007 | EP1212422B1 Human ctla-4 antibodies and their uses |
| 02/21/2007 | EP1141366B1 Transfectacons comprising calcium phosphate and a nucleic acid |
| 02/21/2007 | EP1135503B1 Drug targets in candida albicans |
| 02/21/2007 | EP1097223B1 Expression of herbicide tolerance genes in plant plastids |
| 02/21/2007 | EP1088057B1 Method and medium for in vitro culture of human embryos |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP1071827B1 Mixed cell diagnostic systems |
| 02/21/2007 | EP1000154B1 Identification of human cell lines for the production of human proteins by endogenous gene activation |
| 02/21/2007 | EP0988373B1 Selection marker |
| 02/21/2007 | EP0981381B1 Polyhydroxyalkanoates for in vivo applications |
| 02/21/2007 | EP0901523B1 Immortalized avian cell lines |
| 02/21/2007 | EP0870014B1 Aldolase catalytic antibody |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918296A Toxin complex proteins and genes from xenorhabus bovienii |
| 02/21/2007 | CN1918287A Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof |
| 02/21/2007 | CN1918286A A method and apparatus for orienting spherical cells |
| 02/21/2007 | CN1918285A System and method of up-regulating bone morphogenetic protein (bmp) gene expression in bone cells via the appplication of fields generated by specific and selective electric and electromagnetic signal |
| 02/21/2007 | CN1918284A Stem cells |
| 02/21/2007 | CN1916166A Method for preparing epithelium of autologous cornea |
| 02/21/2007 | CN1916165A Method for in vitro culture of ovarian follicles |
| 02/21/2007 | CN1915439A Biodegradable substrate, prosthetic material for tissue regeneration and cultured tissue |
| 02/21/2007 | CN1915002A Method for inducing embryo callus of larch, and dedicated culture medium |
| 02/21/2007 | CN1915001A Technique for breeding pyrethrum of white flower |
| 02/21/2007 | CN1301327C Human Tumor cell separating and purifying process |
| 02/20/2007 | US7179973 Inbred corn line GS05-32431 |
| 02/20/2007 | US7179972 Plants and seeds of corn variety I006605 |
| 02/20/2007 | US7179971 Inbred maize line PH94T |
| 02/20/2007 | US7179970 Inbred corn line PH7GD |
| 02/20/2007 | US7179969 Plants and seeds of corn variety I181334 |
| 02/20/2007 | US7179968 Plant produced by crossing soybean variety XB36Q06 with another soybean plant, using XB36Q06 as either the male or the female parent; introgressing a transgenic or mutant trait into soybean variety XB36Q06 |
| 02/20/2007 | US7179967 Soybean variety XB15W06 |
| 02/20/2007 | US7179966 Soybean cultivar 11939-31 |
| 02/20/2007 | US7179956 Elevation of oil levels in plants |
| 02/20/2007 | US7179953 Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation |
| 02/20/2007 | US7179904 Useful for modulating transcription of a desired polynucleotide |
| 02/20/2007 | US7179903 Liver specific transcriptional enhancer |
| 02/20/2007 | US7179902 Use of regulatory sequences in transgenic plants |
| 02/20/2007 | US7179901 Renal regulatory elements and methods of use thereof |
| 02/20/2007 | US7179893 Recombinant anti-TNF-α antibodies |
| 02/20/2007 | US7179890 Polypeptides as angiogenesis inhibitors |
| 02/20/2007 | US7179884 Polypeptides; proteolysis splitting; antitumor agents |
| 02/20/2007 | US7179796 Protein phosphatase 1B; oligonucleotide of 8-50 nucleobases targeted to a nucleic acid molecule encoding PTP1B; specifically hybridizes with and inhibits the expression of PTP1B. |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179790 Brain natriuretic peptide |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179650 Providing, in vitro, the cell with a nucleic acid segment encoding a polypeptide comprising wherein a Fas and/or TNFR1 mediated apoptosis pathway is inhibited in the cell |
| 02/20/2007 | US7179649 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 02/20/2007 | US7179648 Susceptible to baculovirus infection, useful for replicating, for gene expression using a baculovirus expression system |
| 02/20/2007 | US7179647 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids |
| 02/20/2007 | US7179646 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 02/20/2007 | US7179644 Kit for use in the generation of preferential expression vectors |
| 02/20/2007 | US7179631 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179622 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179601 Methods of identifying plant disease-resistance genes |
| 02/20/2007 | US7179472 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/20/2007 | US7179467 DCMP2 polypeptide |
| 02/20/2007 | US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon |
| 02/20/2007 | US7179464 Immunoglobulin for use in the treatment and prevention of asthma |
| 02/20/2007 | US7179463 Treatment of alzheimer's disease |
| 02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
| 02/20/2007 | US7179459 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 02/20/2007 | US7179287 Treating with cell growth factors, removing basement membrane from a luminal surface, repopulating with a fibroblastic cells, then with an endothelial cell; apoptosis resistance |
| 02/20/2007 | CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 02/20/2007 | CA2192512C Nm03 antibody materials and methods |
| 02/20/2007 | CA2175628C Production of recombinant factor viii in the presence of liposome-like substances of mixed composition |
| 02/20/2007 | CA2146735C Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes |
| 02/15/2007 | WO2007019398A1 Improved methods of reprogramming animal somatic cells |
| 02/15/2007 | WO2007019267A1 MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR α (TNF-α) AND TREATING HUMAN DISEASES OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-α |
| 02/15/2007 | WO2007019107A2 Adipose tissue stem cells, perivascular cells and pericytes |
| 02/15/2007 | WO2007019055A2 Cell delivery fluid for prevention of cellsettling in delivery system |
| 02/15/2007 | WO2007018318A1 Method for gene expression specific to cerebellar astrocyte and/or basket cell |
| 02/15/2007 | WO2007018199A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007018198A1 Cancer-rejection antigen peptide derived from hsp105 for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 02/15/2007 | WO2007018182A1 Cancer-like mutant |
| 02/15/2007 | WO2007018143A1 Use of gene which varies in amount of expression during the course of transition from precancer to cancer |
| 02/15/2007 | WO2007018062A1 Eucalyptus globulus monoterpene synthetase gene |
| 02/15/2007 | WO2007018047A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |